TARDBP and amyotrophic lateral sclerosis: This is consistent with prior studies in ALS/FTD models showing that ASO‐mediated suppression of TDP‐43 improves behavioural dysfunction, indicating their therapeutic potential for TDP‐43‐related disorders.59